Saturday, July 4, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

NVS — NOVARTIS AG SEC Filings | FilingIndex

NVSNYSE

NOVARTIS AG

Pharmaceutical Preparations · V8 · CIK 1114448

Develops and manufactures innovative medicines and generics to improve and extend people's lives

+ Watch View on EDGAR ↗

$305.10B

Market cap

$159.90

Last close

+3.7%

1D

+3.1%

5D

1.6M

Volume

Price$159.90+29.1%· 1Y

Jul 2L $113.50 · H $168.62Jul 2

608

Total filings

Jun 11, 2026

Last filing

12/31

Fiscal year end

All 6-K · 561 424B5 · 18 20-F · 17 425 · 7 SC 13G · 3 SC 13D · 2

424B5424B5Mar 17, 2026 424B5424B5Mar 16, 2026 424B5424B5Nov 4, 2025 424B5424B5Nov 3, 2025 424B5424B5Sep 17, 2024 424B5

Similar companies

Comparable business profile · signals at a glance

IVAInventiva S.A.$923.6M+6.0%SNYSanofi$103.3B+3.7%TEVATEVA PHARMACEUTICAL INDUSTRIES LTD$40.3B+3.6%NVONOVO NORDISK A S$223.2B+3.4%ABVXAbivax S.A.$11.5B

424B5

Sep 16, 2024

424B5PROSPECTUS SUPPLEMENTFeb 12, 2020

424B5PRELIMINARY PROSPECTUS SUPPLEMENTFeb 11, 2020

424B5PROSPECTUS SUPPLEMENTFeb 15, 2017

424B5PRELIMINARY PROSPECTUS SUPPLEMENTFeb 14, 2017

424B5FINAL PROSPECTUS SUPPLEMENTNov 18, 2015

424B5PRELIMINARY PROSPECTUS SUPPLEMENTNov 17, 2015

424B5FINAL PROSPECTUS SUPPLEMENTFeb 19, 2014

424B5PRELIMINARY PROSPECTUS SUPPLEMENTFeb 18, 2014

424B5424B5Sep 19, 2012

424B5424B5Sep 18, 2012

424B5PROSPECTUS SUPPLEMENTMar 10, 2010

424B5PRELIMINARY PROSPECTUS SUPPLEMENTMar 9, 2010

+9.1%

GSKGSK plc$107.5B+4.6%